S100A9 and psoriasis: This model was implemented and characterized an elevated inflammatory response, evaluated by an increase in IL-6 and IL-8 production, augmentation of S100A7, S100A9, CXCL1, and CCL20 expression, and an increase in the proliferation in HaCaT cells, consistent with the psoriasis-like phenotype.